Evidence map›Paper›PMID 31958596›Full record

ArticleActa biomaterialia2020

Bioresorbable silk grafts for small diameter vascular tissue engineering applications: In vitro and in vivo functional analysis.

Prerak Gupta, Katherine L Lorentz, Darren G Haskett, Eoghan M Cunnane, Aneesh K Ramaswamy, Justin S Weinbaum, David A Vorp, Biman B Mandal

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Electrospun nanofiber scaffold for vascular tissue engineering.Materials science & engineering. C, Materials for biological applications · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Prerak GuptaDepartment of Biosciences and Bioengineering, Indian Istitute of Technology Guwahati, Guwahati 781039, India; McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States.
Katherine L LorentzMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States.
Darren G HaskettMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, United States.
Eoghan M CunnaneMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States; Tissue Engineering Research Group (TERG), Royal College of Surgeons in Ireland (RCSI), Dublin D02 YN77, Ireland.
Aneesh K RamaswamyMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States.
Justin S WeinbaumMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15261, United States.
David A VorpMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA 15261, United States; Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA 15261, United States. Electronic address: vorp@pitt.edu.
Biman B MandalDepartment of Biosciences and Bioengineering, Indian Istitute of Technology Guwahati, Guwahati 781039, India; Centre for Nanotechnology, Indian Institute of Technology Guwahati, Guwahati 781039, India. Electronic address: biman.mandal@iitg.ac.in.
University of Pittsburgh · USIndian Institute of Technology Guwahati · INRoyal College of Surgeons in Ireland · IE

Funding

Vascular Surgery Research Training (VascTrain) ProgramT32HL098036 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Edith Tzeng · 2010 to 2026
$7.2M
Artificial Stem Cells for Vascular Tissue EngineeringR01HL130077 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2016 to 2019
$1.5M
Preclinical optimization and design for manufacturability of immunoregulatory tissue-engineered vascular graftsR61HL154102 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2020 to 2021
$757k
An Autologous, Culture-Free, Adipose Cell-Based Tissue Engineered Vascular GraftR21HL130784 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VORP, DAVID ALAN · 2016 to 2017
$418k
Request for a high resolution microcomputed tomography system for the School of Dental Medicine, University of PittsburghS10OD021533 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VERDELIS, KOSTAS · 2017 to 2017
$323k
NHLBI NIH HHS R01 HL130077NHLBI NIH HHS R21 HL130784NHLBI NIH HHS R61 HL154102NHLBI NIH HHS T32 HL098036NIH HHS S10 OD021533
6 · The paper itself

Abstract

The success of tissue-engineered vascular graft (TEVG) predominantly relies on the selection of a suitable biomaterial and graft design. Natural biopolymer silk has shown great promise for various tissue-engineering applications. This study is the first to investigate Indian endemic non-mulberry silk (Antheraea assama-AA) - which inherits naturally superior mechanical and biological traits (e.g., RGD motifs) compared to Bombyx mori-BM silk, for TEVG applications. We designed bi-layered biomimetic small diameter AA-BM silk TEVGs adopting a new fabrication methodology. The inner layer showed ideally sized (~40 µm) pores with interconnectivity to allow cellular infiltration, and an outer dense electrospun layer that confers mechanical resilience. Biodegradation of silk TEVGs into amino acids as resorbable byproducts corroborates their in vivo remodeling ability. Following our previous reports, we surgically implanted human adipose tissue-derived stromal vascular fraction (SVF) seeded silk TEVGs in Lewis rats as abdominal aortic interposition grafts for 8 weeks. Adequate suture retention strength (0.45 ± 0.1 N) without any blood seepage post-implantation substantiate the grafts' viability. AA silk-based TEVGs showed superior animal survival and graft patency compared to BM silk TEVGs. Histological analysis revealed neo-tissue formation, host cell infiltration and graft remodeling in terms of extracellular matrix turnover. Altogether, this study demonstrates promising aspects of AA silk TEVGs for vascular tissue engineering applications. STATEMENT OF SIGNIFICANCE: Clinical 'off the shelf' implementation of tissue-engineered vascular grafts (TEVGs) remains a challenge. Achieving optimal blood vessel regeneration requires the use of bioresorbable materials having suitable degradation rates while producing minimal or no toxic byproducts. Host cell recruitment and preventing acute thrombosis are other pre-requisites for successful graft remodeling. In this study, for the first time we explored the use of naturally derived Indian endemic non-mulberry Antheraea assama silk in combination with Bombyx mori silk for TEVG applications by adopting a new biomimetic approach. Our bi-layered silk TEVGs were optimally porous, mechanically resilient and biodegradable. In vivo implantation in rat aorta showed long-term patency and graft remodeling by host cell infiltration and extracellular matrix deposition corroborating their clinical feasibility.

Indexed as

Absorbable ImplantsBlood Vessel Prosthesis ImplantationTissue EngineeringAdultAnimalsCell ProliferationExtracellular MatrixFemaleHumansRats, Inbred LewSilkTensile StrengthTissue ScaffoldsSilkBiodegradationNon-mulberry silkTissue engineeringTissue remodelingVascular grafts

Identifiers

PMID31958596
PMCPMC7050402
OpenAlexW3000620838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.